Akorn, Inc. is recalling 10,210 bottles of Betaxolol Ophthalmic Solution (betaxolol hydrochloride), a sterile prescription eye drop. The recall was issued after stability testing at the 12-month mark confirmed a sterility failure, indicating potential microbial contamination. No injuries or adverse events have been reported to date. The product was distributed nationwide to pharmacies and healthcare providers.
Using a contaminated sterile eye product can cause serious eye infections, which may lead to vision loss or other permanent eye damage. Consumers with compromised immune systems or existing eye conditions are at the highest risk of severe complications.
You have 2 options:
Recall #: D-0004-2022; confirmed sterility failure at 12-month stability testing.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.